News

AddToAny

Google+ Facebook Twitter Twitter

New antibiotic resistance gene

Aminoglycoside antibiotics are critically important for treating several types of infections with multi-resistant bacteria.

A completely new resistance gene, which is likely to counteract the newest aminoglycoside drug, plazomycin, was recently discovered by scientists in Gothenburg, Sweden.

The bacterial gene the team discovered in river sediment from India does not resemble any known antibiotic resistance gene.

But when the scientists compared its DNA sequence to already published bacterial DNA sequences, they found that it was already present in several pathogens, including Salmonella and Pseudomonas, from the USA, China and Italy. Until now, no one had realised that it was a resistance gene.

The research team has named the gene “gar”.  

bit.ly/39Mcrrf

 

Picture Credit | iStock

 

Related Articles

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Blue helix human DNA structure-Image credit-shutterstock-1669326868

The search for genes that cause diseases

A new statistical tool developed by researchers at the University of Chicago improves the ability to find genetic variants that cause disease.

pathogenspreadhr-CREDIT-spooky-pooka

Figuring out the threats: Problem-solving with genomics

As the COVID-19 enquiry continues to unpick the tangled threads of the pandemic response, little has been said about one of the most effective weapons against the SARS-Cov-2 virus – pathogen genomics.

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Top